Papers
5
Total Citations
64
H-Index
4
About
Dr. Prasanna Alluri is a leading radiation oncologist whose research focuses on advancing stereotactic partial breast irradiation (S-PBI) for early-stage breast cancer. His major contributions include pioneering dose escalation trials that establish safer, more effective single- and five-fraction radiation regimens after lumpectomy, with careful evaluation of cosmetic outcomes and tumor control. His 2021 phase 1 dose escalation study (23 citations) and cosmetic outcomes analysis (19 citations) provide foundational evidence for hypofractionated partial breast treatments. More recently, Dr. Alluri has integrated artificial intelligence into radiotherapy, developing a multi-task deep learning model (2024, 15 citations) that predicts multimodal dose distributions—a significant step toward personalized, automated treatment planning. His work also includes a preoperative single-fraction ablative trial, exploring neoadjuvant approaches. With a portfolio of clinical trials and translational AI research, Dr. Alluri is shaping the future of breast cancer radiotherapy by reducing treatment burden while maintaining efficacy and quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5